Gastrointestinal agents Market - Growth, Future Prospects, and Competitive Analysis, 2017 - 2025, the global gastrointestinal agents market was valued at US$ 17,255.3 Mn in 2016, and is expected to reach US$ 21,177.7 Mn by 2025, expanding at a CAGR of 2.6% from 2017 to 2025.
Browse Full Report Visit - http://www.acutemarketreports.com/report/global-gastrointestinal-agents-market
Market Insights
Medications for gastrointestinal diseases and symptoms include prescription and nonprescription drugs, conventional and unconventional agents, simple small molecules, complex macromolecules and large recombinant proteins. These medications can be classified based upon their use: drugs for nausea and vomiting (antiemetics), prokinetic agents, laxatives, antidiarrheal agents, drugs for acid peptic disease, drugs for irritable bowel syndrome, inflammatory bowel disease and, of course, miscellaneous. Gastrointestinal disorders include conditions such as constipation, irritable bowel syndrome, hemorrhoids, anal fissures, perianal abscesses, anal fistulas, perianal infections, diverticular diseases, colitis, colon polyps and cancer. Many of these can be prevented or minimized by maintaining a healthy lifestyle, practicing good bowel habits, and submitting to cancer screening.
The global gastrointestinal agents market is segmented by drug type as antidiarrheal, anti-ulcers, laxatives, inflammatory bowel disease drugs and irritable bowel syndrome drugs. Among these, inflammatory bowel disease held the largest share in the gastrointestinal agents market due high prevalence of inflammatory bowel disease in the region.
As of the current market scenario, North America dominates the gastrointestinal agents market. The U.S., in particular captures the largest market share in the Americas gastrointestinal agents market. However, the region is expected to witness flat growth due to maturity of this market and no anticipated competition from potential drug. Asia Pacific is anticipated to be fastest growing market for the forecast period 2017-2015
Market Competition Assessment:
Key players in the global gastrointestinal agents market are
Abbott Laboratories, Allergan Plc. (Formerly Actavis Plc.), AstraZeneca, Bayer AG, Boehringer Ingelheim GmbH, GlaxoSmithKline plc, Janssen Biotech, Inc, Ranbaxy Laboratories Limited, Sanofi, Takeda Pharmaceutical, Valeant Pharmaceuticals, Inc. and others
Key Market Movements:
• Chronic digestive disorders such as irritable bowel syndrome, inflammatory bowel disease have being commonly observed recently. Gastrointestinal (GI) diseases account for substantial morbidity, mortality, and cost. Thus rising incidence of gastrointestinal disease is key driver for market growth
• Enormous research and development is taking place in gastrointestinal therapy in pharma industry where it has seventh largest pipeline products, surpassing other therapy areas such as dermatology, ophthalmology and respiratory. There are many drugs and biologics in pipeline especially in phase 2 and phase 3 clinical trails
Browse All Reports of This Category - http://www.acutemarketreports.com/category/pharmaceutical-market
Chapter 1 Preface
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Methodology
1.2.1 Phase I – Secondary Research
1.2.2 Phase II – Primary Research
1.2.3 Phase III – Expert Panel Review
1.2.4 Assumptions
Chapter 2 Executive Summary
2.1 Global Gastrointestinal Agents Market Portraiture
2.2 Global Gastrointestinal Agents Market Revenue, by Class, 2016 Vs 2025 (Value %)
2.3 Global Gastrointestinal Agents Market Revenue, by Geography, 2016 (US$ Million)
Chapter 3 Global Gastrointestinal Agents Market Analysis
3.1 Global Gastrointestinal Agents Market Overview
3.2 Market Dynamics
3.2.1 Drivers
3.2.1.1 Rise in the instances of gastrointestinal diseases and disorders
3.2.1.2 Active development in pipelines drugs and biologics
3.2.2 Challenges
3.2.2.1 Most of the patient prefers home remedies in its initial stage of diseases
3.2.3 Opportunities
3.2.3.1 Rise in used of OTC drugs and food supplements
3.3 Food Supplements as Supportive Therapy for Gastrointestinal Diseases (2015-2016) (US$)
3.4 Incidence Rate of GERD, IBD and IBS, 2016
3.5 Attractive Investment Proposition
3.6 Competitive Analysis: Key Players in Global Gastrointestinal Agents Market
Chapter 4 Gastrointestinal Agents Market Analysis, by Drug Class, 2015-2025 (US$ Mn)
4.1 Overview
4.2 Antidiarrheal
4.3 Anti-emetics
4.3.1 Anticholinergic Agents
4.3.2 Antihistamines
4.3.3 Serotonin 5-HT3 Receptor Antagonists
4.3.4 Cannabinoid Receptor Agonists
4.4 Anti-ulcers
4.4.1 Histamine type 2 receptor blockers (H2 blockers)
4.4.2 Proton Pump Inhibitors
4.5 Laxatives
4.6 Inflammatory bowel disease
4.6.1 5-Aminosalicyclic Acid (5-ASA) Derivatives
4.6.2 Immunosuppressive Agents
4.6.3 Tumor Necrosis Factor Antagonists
4.7 Irritable bowel syndrome
4.7.1 Antimuscarinics/Antispasmodics
4.7.2 Prokinetic Agents
Chapter 5 Americal Gastrointestinal Agents Market, by Geography, 2015-2025 (US$ Mn)
5.1 Overview
5.2 North Americ (USA and Canada)
5.3 Europe (U.K., Germany & Rest of Europe)
5.4 Asia Pacific (China, Japan, and Rest of Asia Pacific)
5.5 Latin America (Brazil, Mexico and Rest of Latin America)
5.6 Middle East and Africa (UAE, Saudi Arabia, South Africa and Rest of Middle East and Africa)
To Get Complete Report @ http://www.acutemarketreports.com/report/global-gastrointestinal-agents-market
Chapter 6 Company Profiles
6.1 Abbott Laboratories
6.2 Allergan Plc. (Formerly Actavis Plc.)
6.3 AstraZeneca
6.4 Bayer AG
6.5 Boehringer Ingelheim GmbH
6.6 GlaxoSmithKline plc.
6.7 Janssen Biotech, Inc.
6.8 Ranbaxy Laboratories Limited
Browse Full Report Visit - http://www.acutemarketreports.com/report/global-gastrointestinal-agents-market
Market Insights
Medications for gastrointestinal diseases and symptoms include prescription and nonprescription drugs, conventional and unconventional agents, simple small molecules, complex macromolecules and large recombinant proteins. These medications can be classified based upon their use: drugs for nausea and vomiting (antiemetics), prokinetic agents, laxatives, antidiarrheal agents, drugs for acid peptic disease, drugs for irritable bowel syndrome, inflammatory bowel disease and, of course, miscellaneous. Gastrointestinal disorders include conditions such as constipation, irritable bowel syndrome, hemorrhoids, anal fissures, perianal abscesses, anal fistulas, perianal infections, diverticular diseases, colitis, colon polyps and cancer. Many of these can be prevented or minimized by maintaining a healthy lifestyle, practicing good bowel habits, and submitting to cancer screening.
The global gastrointestinal agents market is segmented by drug type as antidiarrheal, anti-ulcers, laxatives, inflammatory bowel disease drugs and irritable bowel syndrome drugs. Among these, inflammatory bowel disease held the largest share in the gastrointestinal agents market due high prevalence of inflammatory bowel disease in the region.
As of the current market scenario, North America dominates the gastrointestinal agents market. The U.S., in particular captures the largest market share in the Americas gastrointestinal agents market. However, the region is expected to witness flat growth due to maturity of this market and no anticipated competition from potential drug. Asia Pacific is anticipated to be fastest growing market for the forecast period 2017-2015
Market Competition Assessment:
Key players in the global gastrointestinal agents market are
Abbott Laboratories, Allergan Plc. (Formerly Actavis Plc.), AstraZeneca, Bayer AG, Boehringer Ingelheim GmbH, GlaxoSmithKline plc, Janssen Biotech, Inc, Ranbaxy Laboratories Limited, Sanofi, Takeda Pharmaceutical, Valeant Pharmaceuticals, Inc. and others
Key Market Movements:
• Chronic digestive disorders such as irritable bowel syndrome, inflammatory bowel disease have being commonly observed recently. Gastrointestinal (GI) diseases account for substantial morbidity, mortality, and cost. Thus rising incidence of gastrointestinal disease is key driver for market growth
• Enormous research and development is taking place in gastrointestinal therapy in pharma industry where it has seventh largest pipeline products, surpassing other therapy areas such as dermatology, ophthalmology and respiratory. There are many drugs and biologics in pipeline especially in phase 2 and phase 3 clinical trails
Browse All Reports of This Category - http://www.acutemarketreports.com/category/pharmaceutical-market
Chapter 1 Preface
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Methodology
1.2.1 Phase I – Secondary Research
1.2.2 Phase II – Primary Research
1.2.3 Phase III – Expert Panel Review
1.2.4 Assumptions
Chapter 2 Executive Summary
2.1 Global Gastrointestinal Agents Market Portraiture
2.2 Global Gastrointestinal Agents Market Revenue, by Class, 2016 Vs 2025 (Value %)
2.3 Global Gastrointestinal Agents Market Revenue, by Geography, 2016 (US$ Million)
Chapter 3 Global Gastrointestinal Agents Market Analysis
3.1 Global Gastrointestinal Agents Market Overview
3.2 Market Dynamics
3.2.1 Drivers
3.2.1.1 Rise in the instances of gastrointestinal diseases and disorders
3.2.1.2 Active development in pipelines drugs and biologics
3.2.2 Challenges
3.2.2.1 Most of the patient prefers home remedies in its initial stage of diseases
3.2.3 Opportunities
3.2.3.1 Rise in used of OTC drugs and food supplements
3.3 Food Supplements as Supportive Therapy for Gastrointestinal Diseases (2015-2016) (US$)
3.4 Incidence Rate of GERD, IBD and IBS, 2016
3.5 Attractive Investment Proposition
3.6 Competitive Analysis: Key Players in Global Gastrointestinal Agents Market
Chapter 4 Gastrointestinal Agents Market Analysis, by Drug Class, 2015-2025 (US$ Mn)
4.1 Overview
4.2 Antidiarrheal
4.3 Anti-emetics
4.3.1 Anticholinergic Agents
4.3.2 Antihistamines
4.3.3 Serotonin 5-HT3 Receptor Antagonists
4.3.4 Cannabinoid Receptor Agonists
4.4 Anti-ulcers
4.4.1 Histamine type 2 receptor blockers (H2 blockers)
4.4.2 Proton Pump Inhibitors
4.5 Laxatives
4.6 Inflammatory bowel disease
4.6.1 5-Aminosalicyclic Acid (5-ASA) Derivatives
4.6.2 Immunosuppressive Agents
4.6.3 Tumor Necrosis Factor Antagonists
4.7 Irritable bowel syndrome
4.7.1 Antimuscarinics/Antispasmodics
4.7.2 Prokinetic Agents
Chapter 5 Americal Gastrointestinal Agents Market, by Geography, 2015-2025 (US$ Mn)
5.1 Overview
5.2 North Americ (USA and Canada)
5.3 Europe (U.K., Germany & Rest of Europe)
5.4 Asia Pacific (China, Japan, and Rest of Asia Pacific)
5.5 Latin America (Brazil, Mexico and Rest of Latin America)
5.6 Middle East and Africa (UAE, Saudi Arabia, South Africa and Rest of Middle East and Africa)
To Get Complete Report @ http://www.acutemarketreports.com/report/global-gastrointestinal-agents-market
Chapter 6 Company Profiles
6.1 Abbott Laboratories
6.2 Allergan Plc. (Formerly Actavis Plc.)
6.3 AstraZeneca
6.4 Bayer AG
6.5 Boehringer Ingelheim GmbH
6.6 GlaxoSmithKline plc.
6.7 Janssen Biotech, Inc.
6.8 Ranbaxy Laboratories Limited
Latest Reports :
http://www.newzmarket.com/2017/07/11/wimbledon-2017-nadal-who-was-exact-retribution-on-mullers-hand/
http://www.newzmarket.com/2017/07/11/wimbledon-2017-nadal-who-was-exact-retribution-on-mullers-hand/
About - Acute Market Reports :
Acute Market Reports is the most sufficient collection of market intelligence services online. It is your only source that can fulfill all your market research requirements.We provide online reports from over 100 best publishers and upgrade our collection regularly to offer you direct online access to the world’s most comprehensive and recent database with expert perceptions on worldwide industries, products, establishments and trends.
Acute Market Reports is the most sufficient collection of market intelligence services online. It is your only source that can fulfill all your market research requirements.We provide online reports from over 100 best publishers and upgrade our collection regularly to offer you direct online access to the world’s most comprehensive and recent database with expert perceptions on worldwide industries, products, establishments and trends.
Our team consists of highly motivated market research professionals and they are accountable for creating the groundbreaking technology that we utilize in our search engine operations to easily recognize the most current market research reports online.
Contact Us :
Name : Chris Paul
ACUTE MARKET REPORTS
Designation : Global Sales Manager
Toll Free(US/CANADA): +1-855-455-8662
Email : sales@acutemarketreports.com
Website : http://www.acutemarketreports.com
Our Blog :- http://www.pdfdevices.com/
